AR044209A1 - Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel - Google Patents

Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel

Info

Publication number
AR044209A1
AR044209A1 ARP040101121A ARP040101121A AR044209A1 AR 044209 A1 AR044209 A1 AR 044209A1 AR P040101121 A ARP040101121 A AR P040101121A AR P040101121 A ARP040101121 A AR P040101121A AR 044209 A1 AR044209 A1 AR 044209A1
Authority
AR
Argentina
Prior art keywords
treatment
pharmaceutical compositions
skin diseases
group
compositions
Prior art date
Application number
ARP040101121A
Other languages
English (en)
Inventor
Minoru Okada
Akira Takahashi
Norimitsu Umehara
Tetsuo Hayashi
Kazuki Matsumoto
Yoichi Onuki
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03008989A external-priority patent/EP1468696A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR044209A1 publication Critical patent/AR044209A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones farmacéuticas para el tratamiento de enfermedades de la piel. Las composiciones comprenden una cantidad anhistamínica eficaz de epinastina o de una sal farmacéuticamente aceptable de ésta como compuesto farmacológicamente activo, y al menos un compuesto seleccionado del grupo que consiste en un o unos aminoácido(s) o péptido(s) que contienen azufre como donantes biológicamente activos de un grupo -S- o -SH-, al menos una vitamina del grupo B, al menos una vitamina con propiedades antioxidantes y una cantidad antiflogísticamente eficaz de un compuesto antiflogístico. Las composiciones también pueden comprender aditivos farmacéuticamente aceptables.
ARP040101121A 2003-04-04 2004-04-02 Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel AR044209A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03007778 2003-04-04
EP03007759 2003-04-04
EP03007779 2003-04-04
EP03008989A EP1468696A1 (en) 2003-04-17 2003-04-17 Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases

Publications (1)

Publication Number Publication Date
AR044209A1 true AR044209A1 (es) 2005-09-07

Family

ID=33136052

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101121A AR044209A1 (es) 2003-04-04 2004-04-02 Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel

Country Status (6)

Country Link
US (1) US20040247686A1 (es)
JP (1) JP2006522053A (es)
AR (1) AR044209A1 (es)
PE (1) PE20040961A1 (es)
TW (1) TW200501963A (es)
WO (1) WO2004087167A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
DE102005001645A1 (de) * 2005-01-13 2006-07-20 Gerhard Dr. Sauermann Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
IL172896A0 (en) * 2005-12-29 2006-06-11 Yeda Res & Dev Cxcr4 inhibition
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
JP4300370B2 (ja) 2007-03-13 2009-07-22 春三 小林 上皮改善剤
EP2164481A2 (de) * 2007-06-08 2010-03-24 Bayer Consumer Care AG Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen
FR2918876B1 (fr) * 2007-07-16 2012-10-05 Oreal Utilisation de lumiere verte pour activer la l-amino acide oxydase
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien
EP2382231A2 (en) * 2009-01-16 2011-11-02 Sederma New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
US20140220136A1 (en) * 2013-02-05 2014-08-07 Bordoloi Biotech, Llc System and method for delivering protease inhibitors
CN106659733A (zh) * 2014-07-01 2017-05-10 E·查康 治疗创伤用局部组合物和方法
PL238310B1 (pl) * 2017-10-31 2021-08-09 Top Energy Set Spolka Z Ograniczona Odpowiedzialnoscia Preparat leczniczy oraz sposób jego uzyskiwania
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
WO2022138826A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩を含有する塗布投与用医薬組成物
CN112915084B (zh) * 2021-04-13 2022-08-02 陕西医药控股医药研究院有限公司 一种治疗老年性皮肤瘙痒症的药物组合物及外用制剂
JP2023066490A (ja) * 2021-10-29 2023-05-16 花王株式会社 経口用顆粒組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517299D0 (en) * 1985-07-09 1985-08-14 Salim A S M Dermatologically active substances
US20020103137A1 (en) * 1997-03-30 2002-08-01 Shiseido Co., Ltd. Method of treating environmental stress
JPH11158025A (ja) * 1997-09-26 1999-06-15 Shiseido Co Ltd 皮膚外用剤
JPH11100320A (ja) * 1997-09-29 1999-04-13 Risuburan:Kk 皮膚外用剤
JP4016128B2 (ja) * 1999-09-09 2007-12-05 東和薬品株式会社 耐光性塩酸エピナスチンフィルムコート錠
JP2001097888A (ja) * 1999-09-28 2001-04-10 Hiroshi Ikeno 外用組成物
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
WO2003002125A2 (en) * 2001-06-29 2003-01-09 Astion A/S Combination of aminosugars and cysteine or cysteine derivatives
JP2003026608A (ja) * 2001-07-10 2003-01-29 Nof Corp 皮膚外用剤組成物
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung

Also Published As

Publication number Publication date
TW200501963A (en) 2005-01-16
WO2004087167A2 (en) 2004-10-14
PE20040961A1 (es) 2005-01-05
WO2004087167A3 (en) 2004-11-25
US20040247686A1 (en) 2004-12-09
JP2006522053A (ja) 2006-09-28

Similar Documents

Publication Publication Date Title
AR044209A1 (es) Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
CO6331425A2 (es) Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida
EA200800798A1 (ru) Фармацевтические композиции, предназначенные для лечения нарушений внутреннего уха
EA200802166A1 (ru) Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
BRPI0519384A2 (pt) misturas sinergÍsticas com efeito inseticida e fungicida
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
PH12020551118A1 (en) Modified lipidated relaxin b chain peptides and their therapeutic use
TR201900542T4 (tr) Ağrı ve/veya enflamasyon tedavisi için bileşimler.
ES2376043T3 (es) Derivados de indazol para el tratamiento de enfermedades inducidas por hsp90.
IL172783A0 (en) Rasgap derived peptide for selectively killing cancer cells
BR0209327A (pt) Composição para tratamento de constipação induzida por drogas
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
EP2077111A4 (en) ANTIDEPRESSANT
UY30847A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
PL1853292T3 (pl) Kompozycja farmaceutyczna, zawierająca związki glutationu i betalainy, do prewencji i do zwalczania raka
PA8549401A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
ATE349221T1 (de) Extrakt mit antitumoraler und antitoxischer wirkung
EA201101246A1 (ru) Инъекционная лекарственная форма для лечения острого ишемического инсульта и черепно-мозговой травмы, способ ее изготовления и применение
AR037496A1 (es) Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables
ATE442864T1 (de) Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff
EA200600998A1 (ru) Фармацевтическая композиция, содержащая цинк-гиалуронановый комплекс, предназначенная для лечения рассеянного склероза
EP1563836A4 (en) ACTIVE SUBSTANCE FOR INHIBITING MATRIX METALOPROTEASE-9 PRODUCTION
AR022348A1 (es) Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior

Legal Events

Date Code Title Description
FB Suspension of granting procedure